Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

IRIX vs ALGN vs GKOS vs HOLX vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IRIX
IRIDEX Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$18M
5Y Perf.-42.8%
ALGN
Align Technology, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$12.09B
5Y Perf.-31.3%
GKOS
Glaukos Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$7.81B
5Y Perf.+242.5%
HOLX
Hologic, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$16.97B
5Y Perf.+42.6%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$159.85B
5Y Perf.+132.8%

IRIX vs ALGN vs GKOS vs HOLX vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IRIX logoIRIX
ALGN logoALGN
GKOS logoGKOS
HOLX logoHOLX
ISRG logoISRG
IndustryMedical - DevicesMedical - DevicesMedical - DevicesMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$18M$12.09B$7.81B$16.97B$159.85B
Revenue (TTM)$51M$4.10B$551M$4.13B$10.58B
Net Income (TTM)$-5M$430M$-189M$544M$2.98B
Gross Margin38.0%67.7%78.1%52.8%66.3%
Operating Margin-6.0%14.4%-15.6%17.5%30.5%
Forward P/E14.8x17.2x43.3x
Total Debt$5M$114M$140M$2.63B$303M
Cash & Equiv.$2M$1.08B$91M$1.96B$3.37B

IRIX vs ALGN vs GKOS vs HOLX vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IRIX
ALGN
GKOS
HOLX
ISRG
StockMay 20May 26Return
IRIDEX Corporation (IRIX)10057.2-42.8%
Align Technology, I… (ALGN)10068.7-31.3%
Glaukos Corporation (GKOS)100342.5+242.5%
Hologic, Inc. (HOLX)100142.6+42.6%
Intuitive Surgical,… (ISRG)100232.8+132.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: IRIX vs ALGN vs GKOS vs HOLX vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GKOS and ISRG are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Intuitive Surgical, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. ALGN and HOLX also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
IRIX
IRIDEX Corporation
The Healthcare Pick

Among these 5 stocks, IRIX doesn't own a clear edge in any measured category.

Best for: healthcare exposure
ALGN
Align Technology, Inc.
The Value Play

ALGN ranks third and is worth considering specifically for value.

  • Lower P/E (14.8x vs 43.3x)
Best for: value
GKOS
Glaukos Corporation
The Growth Leader

GKOS has the current edge in this matchup, primarily because of its strength in growth and momentum.

  • 32.3% revenue growth vs IRIX's -6.2%
  • +47.5% vs ISRG's -16.4%
Best for: growth and momentum
HOLX
Hologic, Inc.
The Income Pick

HOLX is the clearest fit if your priority is income & stability.

  • beta 0.45
  • Beta 0.45 vs ALGN's 1.65
Best for: income & stability
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.5% 10Y total return vs GKOS's 454.5%
  • Lower volatility, beta 1.00, Low D/E 1.7%, current ratio 4.87x
  • Beta 1.00, current ratio 4.87x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthGKOS logoGKOS32.3% revenue growth vs IRIX's -6.2%
ValueALGN logoALGNLower P/E (14.8x vs 43.3x)
Quality / MarginsISRG logoISRG28.2% margin vs GKOS's -34.3%
Stability / SafetyHOLX logoHOLXBeta 0.45 vs ALGN's 1.65
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)GKOS logoGKOS+47.5% vs ISRG's -16.4%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs GKOS's -20.1%, ROIC 15.0% vs -9.2%

IRIX vs ALGN vs GKOS vs HOLX vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IRIXIRIDEX Corporation
FY 2024
Retina
57.2%$28M
Cyclo G Six
26.1%$13M
Product and Service, Other
16.7%$8M
ALGNAlign Technology, Inc.
FY 2025
Clear Aligner
80.4%$3.2B
Scanners And Services
19.6%$790M
GKOSGlaukos Corporation
FY 2019
Glaucoma
97.5%$231M
Corneal Health
2.5%$6M
HOLXHologic, Inc.
FY 2025
Diagnostics
44.6%$1.8B
Breast Health
36.2%$1.5B
Gyn Surgical
16.6%$680M
Skeletal Health
2.7%$109M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

IRIX vs ALGN vs GKOS vs HOLX vs ISRG — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGIRIX

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 3 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 208.9x IRIX's $51M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to GKOS's -34.3%. On growth, GKOS holds the edge at +41.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIRIX logoIRIXIRIDEX CorporationALGN logoALGNAlign Technology,…GKOS logoGKOSGlaukos Corporati…HOLX logoHOLXHologic, Inc.ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$51M$4.1B$551M$4.1B$10.6B
EBITDAEarnings before interest/tax-$2M$790M-$40M$974M$3.8B
Net IncomeAfter-tax profit-$5M$430M-$189M$544M$3.0B
Free Cash FlowCash after capex-$3M$717M-$18M$1000M$2.8B
Gross MarginGross profit ÷ Revenue+38.0%+67.7%+78.1%+52.8%+66.3%
Operating MarginEBIT ÷ Revenue-6.0%+14.4%-15.6%+17.5%+30.5%
Net MarginNet income ÷ Revenue-10.0%+10.5%-34.3%+13.2%+28.2%
FCF MarginFCF ÷ Revenue-5.6%+17.5%-3.4%+24.2%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+7.8%+6.2%+41.2%+2.5%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+25.0%+23.6%-6.3%-9.2%+18.8%
ISRG leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

ALGN leads this category, winning 3 of 6 comparable metrics.

At 29.9x trailing earnings, ALGN trades at a 48% valuation discount to ISRG's 57.2x P/E. On an enterprise value basis, ALGN's 14.0x EV/EBITDA is more attractive than ISRG's 43.3x.

MetricIRIX logoIRIXIRIDEX CorporationALGN logoALGNAlign Technology,…GKOS logoGKOSGlaukos Corporati…HOLX logoHOLXHologic, Inc.ISRG logoISRGIntuitive Surgica…
Market CapShares × price$18M$12.1B$7.8B$17.0B$159.8B
Enterprise ValueMkt cap + debt − cash$20M$11.1B$7.9B$17.6B$156.8B
Trailing P/EPrice ÷ TTM EPS-1.91x29.87x-40.71x30.53x57.19x
Forward P/EPrice ÷ next-FY EPS est.14.84x17.21x43.35x
PEG RatioP/E ÷ EPS growth rate2.63x
EV / EBITDAEnterprise value multiple13.96x17.39x43.28x
Price / SalesMarket cap ÷ Revenue0.36x3.00x15.40x4.14x15.88x
Price / BookPrice ÷ Book value/share8.07x3.03x11.64x3.43x9.10x
Price / FCFMarket cap ÷ FCF24.63x18.44x64.18x
ALGN leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 5 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-109 for IRIX. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRIX's 2.21x. On the Piotroski fundamental quality scale (0–9), ALGN scores 7/9 vs IRIX's 2/9, reflecting strong financial health.

MetricIRIX logoIRIXIRIDEX CorporationALGN logoALGNAlign Technology,…GKOS logoGKOSGlaukos Corporati…HOLX logoHOLXHologic, Inc.ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity-108.7%+10.7%-26.5%+11.0%+16.9%
ROA (TTM)Return on assets-17.9%+6.9%-20.1%+6.1%+14.8%
ROICReturn on invested capital-129.9%+15.4%-9.2%+9.4%+15.0%
ROCEReturn on capital employed-48.8%+14.5%-10.3%+8.8%+16.5%
Piotroski ScoreFundamental quality 0–927376
Debt / EquityFinancial leverage2.21x0.03x0.21x0.52x0.02x
Net DebtTotal debt minus cash$2M-$965M$49M$667M-$3.1B
Cash & Equiv.Liquid assets$2M$1.1B$91M$2.0B$3.4B
Total DebtShort + long-term debt$5M$114M$140M$2.6B$303M
Interest CoverageEBIT ÷ Interest expense389.13x-18.69x8.00x
ISRG leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GKOS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in GKOS five years ago would be worth $17,474 today (with dividends reinvested), compared to $1,377 for IRIX. Over the past 12 months, GKOS leads with a +47.5% total return vs ISRG's -16.4%. The 3-year compound annual growth rate (CAGR) favors GKOS at 31.5% vs IRIX's -23.2% — a key indicator of consistent wealth creation.

MetricIRIX logoIRIXIRIDEX CorporationALGN logoALGNAlign Technology,…GKOS logoGKOSGlaukos Corporati…HOLX logoHOLXHologic, Inc.ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-12.0%+8.2%+20.6%+1.9%-19.9%
1-Year ReturnPast 12 months-9.6%-6.7%+47.5%+35.3%-16.4%
3-Year ReturnCumulative with dividends-54.6%-44.9%+127.6%-8.5%+48.5%
5-Year ReturnCumulative with dividends-86.2%-69.6%+74.7%+16.8%+61.7%
10-Year ReturnCumulative with dividends-90.8%+123.3%+454.5%+124.3%+549.2%
CAGR (3Y)Annualised 3-year return-23.2%-18.0%+31.5%-2.9%+14.1%
GKOS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

HOLX leads this category, winning 2 of 2 comparable metrics.

HOLX is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than ALGN's 1.65 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs IRIX's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIRIX logoIRIXIRIDEX CorporationALGN logoALGNAlign Technology,…GKOS logoGKOSGlaukos Corporati…HOLX logoHOLXHologic, Inc.ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.16x1.65x1.16x0.45x1.00x
52-Week HighHighest price in past year$1.65$208.31$146.75$76.04$603.88
52-Week LowLowest price in past year$0.87$122.00$73.16$53.62$427.84
% of 52W HighCurrent price vs 52-week peak+62.4%+81.0%+91.0%+100.0%+74.5%
RSI (14)Momentum oscillator 0–10041.640.161.569.143.6
Avg Volume (50D)Average daily shares traded124K1.1M674K10.3M1.8M
HOLX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: ALGN as "Buy", GKOS as "Buy", HOLX as "Hold", ISRG as "Buy". Consensus price targets imply 38.3% upside for ISRG (target: $623) vs 3.9% for HOLX (target: $79).

MetricIRIX logoIRIXIRIDEX CorporationALGN logoALGNAlign Technology,…GKOS logoGKOSGlaukos Corporati…HOLX logoHOLXHologic, Inc.ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$203.60$146.67$79.00$622.60
# AnalystsCovering analysts33244255
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.9%0.0%+4.4%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ALGN leads in 1 (Valuation Metrics).

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 2 of 6 categories
Loading custom metrics...

IRIX vs ALGN vs GKOS vs HOLX vs ISRG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IRIX or ALGN or GKOS or HOLX or ISRG a better buy right now?

For growth investors, Glaukos Corporation (GKOS) is the stronger pick with 32.

3% revenue growth year-over-year, versus -6. 2% for IRIDEX Corporation (IRIX). Align Technology, Inc. (ALGN) offers the better valuation at 29. 9x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate Align Technology, Inc. (ALGN) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IRIX or ALGN or GKOS or HOLX or ISRG?

On trailing P/E, Align Technology, Inc.

(ALGN) is the cheapest at 29. 9x versus Intuitive Surgical, Inc. at 57. 2x. On forward P/E, Align Technology, Inc. is actually cheaper at 14. 8x.

03

Which is the better long-term investment — IRIX or ALGN or GKOS or HOLX or ISRG?

Over the past 5 years, Glaukos Corporation (GKOS) delivered a total return of +74.

7%, compared to -86. 2% for IRIDEX Corporation (IRIX). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus IRIX's -90. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IRIX or ALGN or GKOS or HOLX or ISRG?

By beta (market sensitivity over 5 years), Hologic, Inc.

(HOLX) is the lower-risk stock at 0. 45β versus Align Technology, Inc. 's 1. 65β — meaning ALGN is approximately 264% more volatile than HOLX relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for IRIDEX Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — IRIX or ALGN or GKOS or HOLX or ISRG?

By revenue growth (latest reported year), Glaukos Corporation (GKOS) is pulling ahead at 32.

3% versus -6. 2% for IRIDEX Corporation (IRIX). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -25. 0% for Hologic, Inc.. Over a 3-year CAGR, GKOS leads at 21. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IRIX or ALGN or GKOS or HOLX or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -37. 0% for Glaukos Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -17. 1% for GKOS. At the gross margin level — before operating expenses — GKOS leads at 77. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IRIX or ALGN or GKOS or HOLX or ISRG more undervalued right now?

On forward earnings alone, Align Technology, Inc.

(ALGN) trades at 14. 8x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 28. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 38. 3% to $622. 60.

08

Which pays a better dividend — IRIX or ALGN or GKOS or HOLX or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is IRIX or ALGN or GKOS or HOLX or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Hologic, Inc.

(HOLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45), +124. 3% 10Y return). Align Technology, Inc. (ALGN) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HOLX: +124. 3%, ALGN: +123. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IRIX and ALGN and GKOS and HOLX and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IRIX is a small-cap quality compounder stock; ALGN is a mid-cap quality compounder stock; GKOS is a small-cap high-growth stock; HOLX is a mid-cap quality compounder stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IRIX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 22%
Run This Screen
Stocks Like

ALGN

Steady Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Stocks Like

GKOS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Gross Margin > 46%
Run This Screen
Stocks Like

HOLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IRIX and ALGN and GKOS and HOLX and ISRG on the metrics below

Revenue Growth>
%
(IRIX: 7.8% · ALGN: 6.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.